Activation of GABA(B) receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling

Accumulated evidence has suggested that potentiation of cortical GABAergic inhibitory neurotransmission may be a key mechanism in the treatment of schizophrenia. However, the downstream molecular mechanisms related to GABA potentiation remain unexplored. Recent studies have suggested that dopamine D...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Frances Fangjia, Su, Ping, Liu, Fang, Daskalakis, Zafiris J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547758/
https://www.ncbi.nlm.nih.gov/pubmed/23192081
http://dx.doi.org/10.1186/1756-6606-5-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547758/
https://www.ncbi.nlm.nih.gov/pubmed/23192081
http://dx.doi.org/10.1186/1756-6606-5-41

Ejemplares similares